Ergo was Drdgold’s largest segment in fiscal 2023, bringing in $4.11B of $5.50B (75%).
| Segment | FY 2019 | FY 2022 | FY 2023 |
|---|---|---|---|
| Ergo | $3.70B | $4.11B | |
| Revenue | — | — | |
| Fwgr | $1.41B | $1.39B | |
| Total | $5.12B | $5.50B |
Drdgold brought in $5.50B from its two segments in fiscal 2023, the year ended June 30, 2023. That was up 7.4% from $5.12B in fiscal 2022. Ergo was the largest at $4.11B (74.8%), ahead of Fwgr at $1.39B (25.2%).
Compared with fiscal 2022, Ergo grew 10.9% to $4.11B, while Fwgr fell 1.8% to $1.39B.
Drdgold (DRDGF) reports its revenue by segment. In fiscal 2023, Ergo was its largest segment, bringing in $4.11B (74.8% of the total), followed by Fwgr at $1.39B (25.2%).
Ergo was Drdgold's largest segment in fiscal 2023, bringing in $4.11B, or 74.8% of the $5.50B total across its two segments.
Ergo grew faster than Fwgr in fiscal 2023, up 10.9% from $3.70B to $4.11B. Fwgr fell 1.8% to $1.39B.
Every figure comes from Drdgold's annual financial filings, as reported. Each line keeps the name Drdgold gives it, and years follow its fiscal calendar.
Drdgold's revenue by segment goes back to fiscal 2019, with figures through fiscal 2023. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.